2seventy bio, Inc. (TSVT)
NASDAQ: TSVT · Real-Time Price · USD
4.850
+0.050 (1.04%)
Sep 18, 2024, 2:46 PM EDT - Market open
2seventy bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -156.25 | -217.57 | -254.15 | -292.21 | -120.11 | -320.59 | |
| Depreciation & Amortization | 9.58 | 10.29 | 11.53 | 16.35 | 13.19 | 8.79 | |
| Other Amortization | - | - | - | - | - | 3.8 | |
| Asset Writedown & Restructuring Costs | 12.06 | 12.06 | - | - | - | - | |
| Stock-Based Compensation | 21.82 | 32.16 | 41.04 | 54.63 | 61 | 62.05 | |
| Other Operating Activities | -8.71 | -6.39 | 0.32 | 0.87 | -6.4 | 2.86 | |
| Change in Accounts Payable | -2.42 | -0.42 | 0.33 | -0.01 | -13.24 | 14.61 | |
| Change in Unearned Revenue | -11.07 | 11.32 | -22.76 | 4.18 | 8.32 | -16.67 | |
| Change in Other Net Operating Assets | 27.83 | -8.29 | -4.44 | 9.34 | -10.55 | 37.21 | |
| Operating Cash Flow | -150.13 | -166.86 | -228.14 | -206.86 | -67.79 | -207.96 | |
| Capital Expenditures | -4.49 | -13.87 | -30.81 | -11.58 | -22.26 | -59.77 | |
| Sale (Purchase) of Intangibles | - | - | - | -8 | - | - | |
| Investment in Securities | 127.3 | 58.16 | 34.54 | 34.99 | - | - | |
| Other Investing Activities | -1.77 | -0.43 | 0.02 | -33 | - | - | |
| Investing Cash Flow | 164.22 | 43.86 | 3.75 | -17.59 | -22.26 | -59.77 | |
| Issuance of Common Stock | 0.54 | 127.39 | 166.23 | - | - | - | |
| Other Financing Activities | - | - | - | 354.89 | 90.05 | 267.72 | |
| Financing Cash Flow | 0.54 | 127.39 | 166.23 | 354.89 | 90.05 | 267.72 | |
| Net Cash Flow | 14.63 | 4.39 | -58.16 | 130.45 | - | - | |
| Free Cash Flow | -154.61 | -180.72 | -258.95 | -218.43 | -90.05 | -267.72 | |
| Free Cash Flow Margin | -350.44% | -180.03% | -283.02% | -400.63% | -36.29% | -604.39% | |
| Free Cash Flow Per Share | -2.99 | -3.67 | -7.27 | -9.30 | -3.85 | -11.46 | |
| Levered Free Cash Flow | -84.92 | -114.54 | -170.65 | -117.88 | -74.26 | - | |
| Unlevered Free Cash Flow | -84.92 | -114.54 | -170.65 | -117.88 | -74.26 | - | |
| Change in Net Working Capital | -4.5 | 7.68 | 28.09 | -26.66 | 35.79 | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.